Apricus Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82M | Buy |
20,569
+589
| +3% | +$109K | 2.22% | 10 |
|
|
2025
Q1 | $4.19M | Buy |
19,980
+380
| +2% | +$79.6K | 2.49% | 2 |
|
|
2024
Q4 | $3.48M | Buy |
19,600
+230
| +1% | +$40.9K | 2.26% | 10 |
|
|
2024
Q3 | $3.83M | Buy |
19,370
+205
| +1% | +$40.5K | 2.52% | 8 |
|
|
2024
Q2 | $3.29M | Sell |
19,165
-137
| -0.7% | -$23.5K | 2.35% | 10 |
|
|
2024
Q1 | $3.51M | Sell |
19,302
-1,005
| -5% | -$183K | 2.47% | 8 |
|
|
2023
Q4 | $3.15M | Sell |
20,307
-230
| -1% | -$35.6K | 2.4% | 12 |
|
|
2023
Q3 | $3.04M | Buy |
20,537
+470
| +2% | +$69.5K | 2.66% | 10 |
|
|
2023
Q2 | $2.71M | Sell |
20,067
-1,335
| -6% | -$180K | 2.38% | 13 |
|
|
2023
Q1 | $3.41M | Buy |
21,402
+284
| +1% | +$45.3K | 3.11% | 3 |
|
|
2022
Q4 | $3.41M | Sell |
21,118
-164
| -0.8% | -$26.5K | 3.11% | 4 |
|
|
2022
Q3 | $2.86M | Buy |
21,282
+220
| +1% | +$29.5K | 2.84% | 9 |
|
|
2022
Q2 | $3.23M | Sell |
21,062
-1,005
| -5% | -$154K | 2.95% | 5 |
|
|
2022
Q1 | $3.46M | Sell |
22,067
-2,050
| -9% | -$321K | 2.82% | 6 |
|
|
2021
Q4 | $3.27M | Buy |
+24,117
| New | +$3.27M | 2.91% | 4 |
|